A new medical innovation, developed in the UK by Europlaz, has the potential to help improve neonatal care and save the lives of more babies born prematurely or in distress according to the company.
MILPITAS, Calif., Dec. 5, 2024 /PRNewswire/ — LifeSignals, Inc. today announced that the UbiqVue 2A Multiparameter System has received EU MDR Certification, marking another significant milestone in deploying continuous wireless patient monitoring for population health management following FDA 510(k) Clearance last month.
First and only contact force pulsed field ablation (PFA) system engineered to revolutionize care for the hundreds of thousands at risk of death from ventricular tachycardia (VT).
Implantable device works like a tree branch to grab and fling proteins
CLEVELAND, Dec. 4, 2024 /PRNewswire/ — Centerline Biomedical, Inc. (“Centerline”), an innovative leader in cardiovascular navigation and visualization systems, announced that the company has received US Food and Drug Administration (FDA) 510(k) clearance for its new IOPS Guidewire Handle
ShiraTronics announced that it initiated its FDA investigational device exemption (IDE) pivotal trial for its neuromodulation therapy.
WARSAW, Ind., Dec. 4, 2024 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® SoluTion™ Porous Plasma Spray (PPS®) Femur, a total knee implant component offering an alternative for patients with sensitivities to bone cement and/or metal.
WUHAN, China, Dec. 4, 2024 /PRNewswire/ — Rhein Laser Technologies Co., Ltd. is proud to announce that its UroFiber® 60Q SuperPulsed Thulium Fiber Laser System received FDA 510(k) clearance (K242293) on November 19, 2024, marking a significant breakthrough in surgical laser development.
MELVILLE, N.Y., Dec. 4, 2024 /PRNewswire/ — At October’s Inner Circle Invitational in Boca Raton, Cartessa Aesthetics introduced three new technologies to the nearly 400 aesthetic providers in attendance.
NEWPORT BEACH, Calif., Dec. 3, 2024 /PRNewswire/ — Wave Neuroscience, a leader in personalized non-invasive neuromodulation technology, today announced that its proprietary Magnetic EEG Resonance Therapy (MeRT) system has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for adjunctive treatment of Post-Traumatic Stress Disorder (PTSD).